⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GILD News
Gilead Sciences Inc
As the Ebola Epidemic Spreads, NanoViricides Advances Towards a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo
accessnewswire.com
NNVC
GILD
REGN
Global TROP-2 Targeted Therapy Market Set to Reach USD 3.29 Billion by 2031 with an 8.6% CAGR
globenewswire.com
GILD
AZN
PFE
MRK
BMY
BIIB
BNTX
Tumor Microenvironment Modulation Market to Hit USD 3.73 Billion by 2031 with a 7.4% CAGR - Key Trends and Insights
globenewswire.com
BMY
MRK
AZN
PFE
REGN
GILD
AMGN
BE
LLY
IOVA
NVS
Global Cancer Biologics Market Poised to Reach USD 189 Billion by 2035 with a CAGR of 8.9%
globenewswire.com
ABT
ABBV
AMGN
AZN
BNTX
BMY
LLY
GILD
JNJ
MRK
NVS
PFE
SNY
TAK
Non-Small Cell Lung Cancer Market Poised for Robust Expansion at a 6.6% CAGR Through 2036, Driven by Emerging Targeted and Immunotherapy Innovations | DelveInsight
prnewswire.com
PFE
ABBV
RMD
GSK
AZN
BNTX
INCY
IOVA
RGEN
MRK
LLY
IBIO
GILD
AMGN
JNJ
NVS
RIGL
BIIB
Blood Cancer United Welcomes New Board Members & Philanthropy Leadership
prnewswire.com
VVV
BIIB
BMY
GILD
MRK
PFE
AMGN
REGN
JNJ
ABBV
LULU
CGC
CRON
ACB
TLRY
SNDL
CVS
UNH
CI
CNC
HCA
THC
AI
NVDA
MSFT
GOOG
IBM
ORCL
AMD
INTC
QCOM
AMAT
MU
SMCI
ADSK
CBRE
JLL
SPG
PLD
EQIX
AMT
DigiCert Introduces Quantum Central to Help Organizations Prepare for Post-Quantum Cryptography
globenewswire.com
MSFT
GOOG
AMZN
IBM
ORCL
CSCO
NVDA
INTC
AMD
QCOM
AMAT
MU
ADBE
CRM
ACN
T
VZ
CMCSA
NFLX
DIS
BA
GD
LMT
RTX
HON
GE
CAT
JPM
BAC
WFC
C
GS
MS
AXP
V
MA
PYPL
KO
PEP
MCD
SBUX
COST
WMT
HD
UNH
JNJ
PFE
MRK
ABBV
BMY
LLY
GILD
AMGN
BIIB
REGN
VRTX
GNTX
CTAS
PAYX
ADP
LRCX
KLAC
NXPI
MRVL
SNPS
CDNS
MCHP
ON
ADI
TXN
QGEN
ILMN
MDT
SYK
ISRG
ALGN
EW
TMO
DHR
GOOGL
AAPL
META
TSLA
Kinaset Therapeutics Appoints Daniel G. Welch as Board Chair and David Lubner as Independent Director and Audit Committee Chair
businesswire.com
ULTA
CRSP
GILD
PFE
NVS
REGN
UCB
LLY
BIIB
ARCL
Kite Helps Fund American Cancer Society's Expanded Efforts to Advance Innovation and Improve Support for People Facing Blood Cancers
prnewswire.com
GILD
U.S. FDA Approves Trodelvy ® for First-Line Treatment of Metastatic Triple-Negative Breast Cancer
businesswire.com
GILD